Dosing guidelines for fluconazole in patients with renal failure

被引:31
作者
Cousin, L [1 ]
Le Berre, M [1 ]
Launay-Vacher, V [1 ]
Izzedine, H [1 ]
Deray, G [1 ]
机构
[1] Hop La Pitie Salpetriere, Dept Nephrol, F-75013 Paris, France
关键词
CAPD; CVVH; fluconazole; haemodialysis; renal insufficiency;
D O I
10.1093/ndt/gfg363
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:2227 / 2231
页数:5
相关论文
共 27 条
[1]  
ANDREU CMF, 1999, REV CUBANA MED TROP, V51, P55
[2]  
BERL T, 1995, J AM SOC NEPHROL, V6, P242
[3]   INCREASED GASTRIC PH AND THE BIOAVAILABILITY OF FLUCONAZOLE AND KETOCONAZOLE [J].
BLUM, RA ;
DANDREA, DT ;
FLORENTINO, BM ;
WILTON, JH ;
HILLIGOSS, DM ;
GARDNER, MJ ;
HENRY, EB ;
GOLDSTEIN, H ;
SCHENTAG, JJ .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (09) :755-757
[4]  
BRAMMER KW, 1991, DRUG METAB DISPOS, V19, P764
[5]  
BREN A, 1992, TRANSPL P, V24, P2765
[6]   Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis [J].
Dahl, NV ;
Foote, EF ;
Searson, KM ;
Fein, JL ;
Kapoian, T ;
Steward, CA ;
Sherman, RA .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) :1284-1289
[7]   CLINICAL PHARMACOKINETICS OF FLUCONAZOLE [J].
DEBRUYNE, D ;
RYCKELYNCK, JP .
CLINICAL PHARMACOKINETICS, 1993, 24 (01) :10-27
[8]  
DUDLEY MN, 1990, PHARMACOTHERAPY, V10, pS141
[9]   FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1990, 39 (06) :877-916
[10]   PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS [J].
HUMPHREY, MJ ;
JEVONS, S ;
TARBIT, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :648-653